Status:
UNKNOWN
Long-term Oxygen Treatment (LTOT) in Chronic Obstructive Pulmonary Disease: Factors Influencing Survival
Lead Sponsor:
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-75 years
Brief Summary
The purpose of this prospective cohort study is to determine factors involved in survival in new COPD patients treated by long-term oxygen therapy. Background: long-term oxygen therapy is indicated i...
Detailed Description
long-term oxygen therapy prolongs life in patients with severe COPD and severe resting hypoxemia. The objective of this study is to measure the survival in relation to the level of initial resting hyp...
Eligibility Criteria
Inclusion
- COPD patients on necessity of long-term oxygen therapy
- Patients treated by LTOT, with or without clinically fulfilled criteria for LTOT, with PaO2\<55mmHg or less at rest or during sleeping or less during exercise, if supplemental oxygen is demonstrated to improve the exercise-associated hypoxia. Patients with PaO2 56-59mmHg if they also have dependent edema, pulmonary hypertension or hematocrit higher than 56%
- Patient clinically stable
- Patient with oxygen device of ANTADIR network
- Oral and written consent
Exclusion
- Patient with obstructive sleep apnea or overlap syndrome
- Patient with non invasive ventilation
- Patient with evolutive cancer.
- Inability to complete questionnaires
- Inability to attend outpatient clinic
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00871962
Start Date
June 1 2009
End Date
May 1 2016
Last Update
June 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pneumologie, Hôpital du Cluzeau
Limoges, France, 87042